|
| Press Releases |
|
 |
|
| Wednesday, August 20, 2025 |
|
|
Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle |
| In the first half of 2025, the structural transformation of the pharmaceutical industry continued to deepen. Driven by favorable policies, product upgrades, and technological innovation, the vaccine industry maintained a stable and positive growth momentum. more info >> |
|
|
創新疫苗引擎持續驅動 康希諾開啟新增長週期 |
| 2025年上半年，醫藥行業結構性轉型持續深化，在政策利好、產品升級與技術革新的共同推動下，疫苗產業呈現出穩中向好的發展態勢。 more info >> |
|
|
创新疫苗引擎持续驱动 康希诺开启新增长周期 |
| 2025年上半年，医药行业结构性转型持续深化，在政策利好、产品升级与技术革新的共同推动下，疫苗产业呈现出稳中向好的发展态势。作为中国创新疫苗领域的领军企业，康希诺生物（上交所代码：688185.SH，联交所代码：6185.HK）再度交出一份稳健发展的成绩单。 more info >> |
|
| Saturday, June 21, 2025 |
|
|
康希諾重磅推出優佩欣疫苗 為兒童健康保駕護航的創新之選 |
| 在看似平靜的日常生活中，一種名為「肺炎球菌」的細菌正悄然威脅著兒童的健康。這種在人體鼻咽部「潛伏」的條件致病菌，平時可能毫無症狀，但一旦免疫力下降便會興風作浪，引發一系列疾病。 more info >> |
|
| Friday, June 20, 2025 |
|
|
CanSinoBIO Launches Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health |
| Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to life-threatening illness. It is also the single largest infectious cause of death in children worldwide. more info >> |
|
|
康希诺重磅推出优佩欣疫苗 为儿童健康保驾护航的创新之选 |
| 在看似平静的日常生活中，一种名为“肺炎球菌”的细菌正悄然威胁着儿童的健康。这种在人体鼻咽部“潜伏”的条件致病菌，平时可能毫无症状，但一旦免疫力下降便会兴风作浪，引发一系列疾病。 more info >> |
|
| Tuesday, March 25, 2025 |
|
|
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong |
| CanSino Biologics Inc. (Stock Code: 688185.SH, 6185.HK, 'CanSinoBIO' or the 'Company'), a leading player in China's vaccine industry, achieved significant revenue growth in 2024, driven by continuous R&D innovation and strong commercial capabilities. more info >> |
|
|
收入狂飙同比增长137% 多款产品蓄势以待 康希诺增长动能充沛 |
| 康希诺生物股份公司（股份代码：688185.SH和6185.HK，以下简称：康希诺）作为中国疫苗领域的佼佼者，凭借持续的研发创新和强大的商业化能力，在2024年实现了显著的业绩增长。 more info >> |
|
| Wednesday, October 9, 2024 |
|
|
CanSino Receives Another Strong Boost |
| CanSino Biologics Inc. ("CanSinoBIO" or "the Company") has announced a milestone in its fight against polio. more info >> |
|
| Thursday, August 29, 2024 |
|
|
CanSinoBIO Reports Outstanding H1 2024 Performance |
| CanSino Biologics Inc. (CanSinoBIO) today disclosed its performance report for the first half of 2024, with revenue reaching 303 million yuan, while losses were substantially reduced. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
華營控股捐贈港幣一百萬元 支援大埔火災災民
Dec 22, 2025 18:17 HKT/SGT
|
|
|
Sri Lanka and the Middle East's top real estate achievements recognised at 2025 PropertyGuru Asia Property Awards
Dec 22, 2025 16:57: JST
|
|
|
MiniMax通過港交所聆訊 衝刺「AGI全球第一股」
Dec 22, 2025 15:59 HKT/SGT
|
|
|
MiniMax通过港交所聆讯 冲刺「AGI全球第一股」
Dec 22, 2025 15:46 HKT/SGT
|
|
|
三菱重工グループ、デジタル人材育成を加速
Dec 22, 2025 12:00: JST
|
|
|
聯想之星收穫第10個IPO
Dec 22, 2025 11:41 HKT/SGT
|
|
|
国内初、三菱重工とエクシオグループが二相式DLC方式のGPUサーバー構築・商用利用開始
Dec 22, 2025 11:40: JST
|
|
|
联想之星收获第10个IPO
Dec 22, 2025 11:30 HKT/SGT
|
|
|
印象大紅袍宣佈全球發售定價 每股發售股份發售價3.6港元 集資港幣1.3億元
Dec 22, 2025 10:00 HKT/SGT
|
|
|
印象大红袍宣布全球发售定价 每股发售股份发售价3.6港元 集资港币1.3亿元
Dec 22, 2025 10:00 HKT/SGT
|
|
|
Sri Lanka and the Middle East's top real estate achievements recognised at 2025 PropertyGuru Asia Property Awards
Dec 22, 2025 09:00 HKT/SGT
|
|
|
西藏智汇矿业登陆港股：从高原走向国际 独特资源禀赋释放长期增长潜力
Dec 19, 2025 16:15 HKT/SGT
|
|
|
西藏智匯礦業登陸港股：從高原走向國際 獨特資源稟賦釋放長期增長潛力
Dec 19, 2025 15:35 HKT/SGT
|
|
|
A New Benchmark for Specialized Technology Stocks in Hong Kong! CiDi's Listing Marks a New Chapter in Commercial Intelligent Driving
Dec 19, 2025 10:30 HKT/SGT
|
|
|
トヨタ、米国生産トヨタ車の26年からの日本導入を検討
Dec 19, 2025 10:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
